Cover Image

Dexamethasone-cyclophosphamide pulse therapy in progressive systemic sclerosis

Saved in:

Bibliographic Details
Main Authors:	Viswanath Vishalakshi (Author), Sonavane Amey (Author), Doshi Aditi (Author), Parab Mrunal (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2010-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dexamethasone cyclophosphamid pulse therapy in pemphigus-appraisal of its outcome
by: Prabhash Kulhari, et al.
Published: (2012)

Dexamethasone- cyclophosphamide pulse in collagen vascular diseases: An observation
by: Sudip Das, et al.
Published: (2011)

Hiccups Following Dexamethasone- Cyclophosphamide Pulse Therapy In a Patient With Oral Pemphigoid
by: Pai Sathish, et al.
Published: (1997)

Dexamethasone Cyclophosphamide Pulse Therapy In Pemphigus- A Five Year Retrospective Study
by: Dogra Alka, et al.
Published: (2003)

Successful remission of early-onset pediatric diffuse systemic sclerosis with suprapharmacological pulse dosing of dexamethasone and cyclophosphamide: A case report
by: Maitreyee Panda, et al.
Published: (2022)

Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proposition? A study from kashmir
by: Sameem Farah, et al.
Published: (2010)

Dexamethasone-Cyclophosphamide Pulse Therapy In Pemphigus : An Appraisal OF Its Outcome In A Tertiary Health Care Center In South India
by: Thappa Devinder Mohan, et al.
Published: (2004)

Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study
by: Ludmilla Figueiredo Fontenelle, et al.
Published: (2023)

Increased incidence of tuberculosis in patients of systemic sclerosis on dexamethasone pulse therapy: A short communication from Kashmir
by: Ahmad Qazi, et al.
Published: (2008)

A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021)

Newer Concepts In Intravenous Glucocorticoid And Cyclophosphamide Pulse Therapy In Dermatology
by: Thappa Devinder Mohan, et al.
Published: (2003)

Intravenous Dexamethasone Pulse Therapy For Extensive Alopecia Areata
by: Thappa Devinder Mohan
Published: (1999)

Pyoderma Gangrenosum In A Child : Treated With Dexamethasone Pulse Therapy
by: Shroff S, et al.
Published: (1998)

Systemic sclerosis: Current concepts in pathogenesis and therapeutic aspects of dermatological manifestations
by: Vishalakshi Viswanath, et al.
Published: (2013)

Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide
by: S. Bombardieri, et al.
Published: (2011)

Peyronie's disease treated with oral weekly dexamethasone and continuous low-dose cyclophosphamide
by: Ramji Gupta, et al.
Published: (2014)

Comparison of the Clinical Efficacy of Rituximab Infusion and Dexamethasone-Cyclophosphamide Pulse Therapy and Their Effect on Serum Th1, Th2, and Th17 Cytokines in Pemphigus Vulgaris-A Prospective, Nonrandomized, Comparative Pilot Study
by: Sujay Khandpur, et al.
Published: (2024)

Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: A case-control study
by: Kanno Tokiko, et al.
Published: (2011)

Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide
by: Renan Bernardes de Mello, et al.
Published: (2019)

Improvement in lesions of co-existing lichen amyloidosis and vitiligo with dexamethasone oral mini pulse therapy
by: Sushama, et al.
Published: (2023)

Aortic pulse wave velocity measurement in systemic sclerosis patients
by: M. Sebastiani, et al.
Published: (2012)

Reduced weekly subcutaneous doses of bortezomib in combination with cyclophosphamide and dexamethasone for newly diagnosed multiple myeloma
by: Farzaneh Ashrafi, et al.
Published: (2020)

Pulsoterapia com ciclofosfamida nos pênfigos: relato de sete casos Cyclophosphamide pulse therapy for pemphigus: report of seven cases
by: Nurimar C. Fernandes, et al.
Published: (2005)

Clinical, CT profile of wistar rats receiving therapeutic doses of alendronate alone and in combination with cyclophosphamide and dexamethasone
by: David Bienvenue Ntep Ntep, et al.
Published: (2022)

Progressive systemic sclerosis in a child
by: Arun K De, et al.
Published: (2013)

Esophageal involvement in progressive systemic sclerosis
by: Stephen A. Geller, et al.
Published: (2013)

Therapeutic approach of Lyell syndrome with infliximab and dexamethasone pulse: report of a clinical case
by: Jânia Dara Jácome Pacheco, et al.
Published: (2022)

Progressive systemic sclerosis - Report of two cases
by: N Malathi, et al.
Published: (2010)

Progressive System Sclerosis - A Case Report
by: Jyothi S Kumar, et al.
Published: (2003)

Therapy of systemic sclerosis
by: G. Valentini
Published: (2004)

Research progress on the acupuncture and external medicine for systemic sclerosis
by: ZHENG Huiyan, et al.
Published: (2024)

Comparative study of intravenous methylprednisolone pulse therapy versus oral prednisolone minipulse therapy in progressive vitiligo
by: K A Rajeshwari, et al.
Published: (2023)

Improvement of iron-deficiency anemia resulting from gastric antral vascular ectasia in patients with systemic sclerosis: cyclophosphamide versus argon plasma coagulation
by: Amr T El-Hawary, et al.
Published: (2018)

Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis
by: Yan Zhang, et al.
Published: (2023)

Progressive systemic sclerosis in a child: A rare phenomenon
by: Savita Arya, et al.
Published: (2017)

Plasmapheresis and Cyclophosphamide therapy in an eight year old girl with cerebral manifestation of systemic lupus erythematodes
by: Emminger W, et al.
Published: (2011)

Pulse dexamethasone and lenalidomide in Rosai Dorfman disease: Efficacy and tolerability of an oral combination chemotherapy regimen for symptomatic and recurrent disease
by: Kavitha Ganesan, et al.
Published: (2022)

Advances in targeted therapies for systemic sclerosis
by: Rong XIAO, et al.
Published: (2024)

Factors affecting the duration of phase 1 of dexamethasone-immunosuppressant pulse therapy for pemphigus group of disorders: A 10-year retrospective study in a tertiary care center
by: Vidya Mundakkat, et al.
Published: (2018)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
by: Sandi L. Navarro, et al.
Published: (2022)